AdAlta Limited (1AD.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 3.54 Million AUD | -39.16% |
| 2023 | 5.82 Million AUD | 10.5% |
| 2022 | 5.27 Million AUD | 97.9% |
| 2021 | 2.66 Million AUD | -16.92% |
| 2020 | 3.2 Million AUD | 76.22% |
| 2019 | 1.81 Million AUD | 396.54% |
| 2018 | 366.31 Thousand AUD | 6.33% |
| 2017 | 344.51 Thousand AUD | 201.86% |
| 2016 | 114.13 Thousand AUD | -56.3% |
| 2015 | 261.18 Thousand AUD | -8.98% |
| 2014 | 286.94 Thousand AUD | -11.39% |
| 2013 | 323.82 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 3.54 Million AUD | -39.16% |
| 2024 Q2 | 2.87 Million AUD | 0.0% |
| 2024 Q4 | 3.54 Million AUD | 0.0% |
| 2023 Q2 | 4.96 Million AUD | 0.0% |
| 2023 FY | 5.82 Million AUD | 10.5% |
| 2023 Q4 | 5.82 Million AUD | 0.0% |
| 2022 Q2 | 3.73 Million AUD | 0.0% |
| 2022 Q4 | 5.27 Million AUD | 0.0% |
| 2022 FY | 5.27 Million AUD | 97.9% |
| 2021 Q2 | 1.23 Million AUD | 0.0% |
| 2021 Q4 | 2.66 Million AUD | 0.0% |
| 2021 FY | 2.66 Million AUD | -16.92% |
| 2020 Q2 | 1.94 Million AUD | 0.0% |
| 2020 FY | 3.2 Million AUD | 76.22% |
| 2020 Q4 | 3.2 Million AUD | 0.0% |
| 2019 FY | 1.81 Million AUD | 396.54% |
| 2019 Q2 | 759.16 Thousand AUD | 0.0% |
| 2019 Q4 | 1.81 Million AUD | 0.0% |
| 2018 Q4 | 366.31 Thousand AUD | 0.0% |
| 2018 FY | 366.31 Thousand AUD | 6.33% |
| 2018 Q2 | 999.28 Thousand AUD | 0.0% |
| 2017 FY | 344.51 Thousand AUD | 201.86% |
| 2017 Q4 | 344.51 Thousand AUD | 0.0% |
| 2017 Q2 | 596.58 Thousand AUD | 0.0% |
| 2016 Q3 | 215.19 Thousand AUD | 0.0% |
| 2016 FY | 114.13 Thousand AUD | -56.3% |
| 2016 Q1 | - AUD | 0.0% |
| 2016 Q4 | 215.19 Thousand AUD | 0.0% |
| 2015 FY | 261.18 Thousand AUD | -8.98% |
| 2014 FY | 286.94 Thousand AUD | -11.39% |
| 2013 FY | 323.82 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Biome Australia Limited | 5.37 Million AUD | 34.071% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 92.072% |
| Biotron Limited | 737.5 Thousand AUD | -380.341% |
| Acrux Limited | 5.68 Million AUD | 37.708% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 34.708% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 5.078% |
| BTC Health Limited | 203.94 Thousand AUD | -1636.989% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 72.33% |
| CSL Limited | 27.88 Billion AUD | 99.987% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 57.481% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 87.399% |
| Immutep Limited | 10.97 Million AUD | 67.735% |
| Memphasys Limited | 5.59 Million AUD | 36.654% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 91.716% |
| Noxopharm Limited | 1.28 Million AUD | -174.912% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -52.331% |
| Race Oncology Limited | 1.91 Million AUD | -84.852% |
| Starpharma Holdings Limited | 8.69 Million AUD | 59.272% |
| Tissue Repair Ltd | 1.35 Million AUD | -162.236% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 16.235% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -1054.495% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -861.486% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 62.138% |
| Patrys Limited | 691.36 Thousand AUD | -412.4% |
| Orthocell Limited | 22.08 Million AUD | 83.958% |
| Imugene Limited | 33.14 Million AUD | 89.311% |
| PYC Therapeutics Limited | 10.18 Million AUD | 65.215% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -117.879% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -202.51% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -72.25% |
| Nanollose Limited | 465.64 Thousand AUD | -660.788% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -720.739% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -4034.49% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -3.378% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -238.798% |
| Nyrada Inc. | 855.63 Thousand AUD | -314.027% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 98.58% |
| Dimerix Limited | 13.89 Million AUD | 74.501% |
| PharmAust Limited | 896.6 Thousand AUD | -295.107% |
| Hexima Limited | 248.67 Thousand AUD | -1324.601% |
| AnteoTech Limited | 4.07 Million AUD | 13.072% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 1.166% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 77.711% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -276.251% |
| Actinogen Medical Limited | 1.61 Million AUD | -119.303% |
| Immuron Limited | 2.84 Million AUD | -24.715% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -45.981% |